HBeAg 诱导中性粒细胞活化,损害慢性乙型肝炎患者 NK 细胞功能。

HBeAg induces neutrophils activation impairing NK cells function in patients with chronic hepatitis B.

机构信息

The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.

Senior Department of Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.

出版信息

Hepatol Int. 2024 Aug;18(4):1122-1134. doi: 10.1007/s12072-024-10689-z. Epub 2024 Jun 3.

Abstract

BACKGROUND

The role of neutrophils in hepatitis B virus (HBV) infection has been a subject of debate due to their involvement in antiviral responses and immune regulation. This study aimed to elucidate the neutrophil characteristics in patients with chronic hepatitis B (CHB).

METHODS

Through flow cytometry and ribonucleic acid-sequencing analysis, the phenotypes and counts of neutrophils were analyzed in patients with CHB. Moreover, the effects of HBeAg on neutrophils and the corresponding pattern recognition receptors were identified. Simultaneously, the cross-talk between neutrophils and natural killer (NK) cells was investigated.

RESULTS

Neutrophils were activated in patients with CHB, characterized by higher expression levels of programmed death-ligand 1 (PD-L1), cluster of differentiation 86, and interleukin-8, and lower levels of CXC motif chemokine receptor (CXCR) 1 and CXCR2. Hepatitis B e antigen (HBeAg) partially induces neutrophil activation through the Toll-like receptor 2 (TLR2). A consistent upregulation of the TLR2 and HBeAg expression was observed in patients with CHB. Notably, the genes encoding molecules pivotal for NK-cell function upon NK receptor engagement enriched in neutrophils after HBeAg activation. The HBeAg-activated neutrophils demonstrated the ability to decrease the production of interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α) in NK cells, while the PD-1 and PD-L1 pathways partially mediated the immunosuppression.

CONCLUSIONS

The immunosuppression of neutrophils induced by HBeAg suggests a novel pathogenic mechanism contributing to immune tolerance in patients with CHB.

摘要

背景

由于中性粒细胞在抗病毒反应和免疫调节中的作用,其在乙型肝炎病毒(HBV)感染中的作用一直存在争议。本研究旨在阐明慢性乙型肝炎(CHB)患者中性粒细胞的特征。

方法

通过流式细胞术和核糖核酸测序分析,分析了 CHB 患者中性粒细胞的表型和计数。此外,确定了 HBeAg 对中性粒细胞及其相应模式识别受体的作用。同时,研究了中性粒细胞与自然杀伤(NK)细胞之间的串扰。

结果

CHB 患者的中性粒细胞被激活,其特征是程序性死亡配体 1(PD-L1)、分化群 86 和白细胞介素 8 的表达水平升高,而 CXC 基序趋化因子受体(CXCR)1 和 CXCR2 的水平降低。乙型肝炎 e 抗原(HBeAg)通过 Toll 样受体 2(TLR2)部分诱导中性粒细胞的激活。在 CHB 患者中观察到 TLR2 和 HBeAg 表达的一致上调。值得注意的是,在 HBeAg 激活后,编码在 NK 受体结合后对 NK 细胞功能至关重要的分子的基因在中性粒细胞中富集。HBeAg 激活的中性粒细胞表现出降低 NK 细胞产生干扰素-γ(IFN-γ)和肿瘤坏死因子-α(TNF-α)的能力,而 PD-1 和 PD-L1 途径部分介导了免疫抑制。

结论

HBeAg 诱导的中性粒细胞免疫抑制提示了一种新的致病机制,有助于 CHB 患者的免疫耐受。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索